Research prototype, not medical advice.
Claims › C-0201-ambar-plasma-exchange-alzheimer
In the AMBAR phase IIb/III trial, plasma exchange with albumin slowed decline in moderate Alzheimer on some outcomes, with mixed results.
Confidence Debated
Level of evidence ●●●●●○ Randomized clinical trial
Observed in Human
Mission Map of aging (12 hallmarks)
Concepts Altered intercellular communication Old plasma dilution / plasma exchange with albumin Alzheimer's disease
What the sources say
Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).